Summary:
UK company is offering their hot extrusion facilities to partners looking to develop API (active pharmaceutical ingredient) from early phase clinical development to large scale commercial production. They are the first GMP (Good Manufacturing Practices) company in the UK with hot extrusion facilities, and can also help partners with their contract research & manufacturing requirement in pharmaceutical new dosage, via manufacturing agreement.
Description:
The UK company is a manufacturing and testing organisation, outfitted with a well-equipped tablet development lab and a complete hot-melt extrusion line.
The company provides advanced insights into drug development and formulation through advanced API (Active Pharmaceutical Ingredient) screening, economical manufacturing process and thorough physiochemical characterisation in order to develop safe and effective dosage forms.
They are looking for pharmaceutical companies to take advantage of their unique manufacturing capacity, to use in the product development of children dosage forms of orally disintegrating tablets (ODTs), improving solubility, bio-availability, absorption of drug, stability improvement, drug manufacturing using co-crystal technology to improve solubility, bioavailability, absorption and stability
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
The UK company is offering manufacturing agreement to companies interested in doing product development of children dosage forms of orally disintegrating tablets (ODTs), improving solubility, bio-availability, absorption of drug, stability improvement, drug manufacturing using co-crystal technology to improve solubility, bioavailability, absorption and stability.
The UK company outsources contract research & manufacturing requirement in pharmaceutical new dosage forms.
Stage of Development:
Already on the market
IPR Status:
Patents granted
Comments Regarding IPR Status:
Three patents in Drug Delivery Systems in UK Intellectual Property Office now published and international patent for Ibuprofen Manufacturing using Hot Melt Extrusion.
External code:
TOUK20201022001
